[ad_1]
London, United Kingdom, December 10, 2021 (Global News Agency)-Tianrong Internet Products and Services Company (OTC:hint), a medical technology and medical device investment company, today announced that it has selected Cambridge Orthopaedic Laboratory Limited (“COL”) ( https://www.wiltongroup.com/col/) As its next equity acquisition candidate. COL is a medical device company that has developed an innovative non-invasive external fixator (PolyArmour) for the treatment of fractures, initially focusing on wrist fractures. COL management expects that the product will be approved by the US FDA as a Class 1 device in the first half of the year In 2022, before launching in the US market later this year. Financial terms have not been disclosed.
Investment advice-Cambridge Orthopedic Labs (COL)
The management of TIPS believes that PolyArmour’s published clinical trial data shows that the product can provide a better patient experience and healing results compared to alternative invasive treatments on the market today, and has a cost for healthcare providers Benefits, there is no need to treat fractures in the operating room, thereby providing TIPS investors with a huge return on investment potential. Wilton, the major shareholder of TIPS, has been cooperating with COL throughout 2021 to promote the company’s…
The full story on Benzinga.com
[ad_2]
Source link
